Collagen makes up almost 70 per cent of the skin's dermis. As it depletes with age, a person tends to look older. Now, a new dermal filler, Evolence, is all set to take the market by storm. Manufactured by ColBar LifeScience , this product replaces lost collagen with an advanced collagen compound and gives one a naturally younger-looking skin.

Highlights of Evolence
a. This is a new collagen based dermal filler.
b. This collagen is derived from porcine (pig) tendons.
c. It works through the GLYMATRIX Technology, which cross-links the collagen with a natural sugar, not synthetic chemicals or substances.
d. It improves and refreshes the skin.
e. It smoothes out and softens facial lines, wrinkles, and folds.
f. It restores the structure and contour of the face in volume-depleted areas.
g. There is hardly any downtime.
h. Results last for about a year.
i. It is administered by a trained physician or healthcare professional.
j. Just one visit is enough for results to show.
k. Results are instant.

Disadvantage
a. Some allergic reaction, though rare, is possible in some people.
b. It might cause some bleeding or bruising on the injection site.
c. It should not be used around the eyes and border of the lips.
d. It should be avoided by pregnant or breast-feeding women, patients with hypersensitivity to any collagen products.
e. It should not be used in breast augmentation or implantation into bone, tendon, ligament or muscle.

Cost
£380 - £450 per syringe